Christina Yfanti

2PUBLICATIONS
2CO-AUTHORS
Molecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Nov 22, 2023
A phase 1 trial of AP30663, a KCa2 channel inhibitor in development for conversion of atrial fibrillation.

Christina Yfanti, Birgitte Vestbjerg, Juliette Van't Westende

Pageof 1